SARS-CoV-2 Transmission and Epidemic Characteristics  in Jining City, China

Jianwei Zhou; Yu Li; Cui Kong; Jiang Yu; Yizhao Li; Qinghua Zhang; Yao Liang

doi:10.15850/amj.v8n2.2373

SARS-CoV-2 Transmission and Epidemic Characteristics in Jining City, China

Jianwei Zhou, Yu Li, Cui Kong, Jiang Yu, Yizhao Li, Qinghua Zhang, Yao Liang

Abstract

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes severe acute respiratory syndrome has spread to hundreds of countries and infected millions of people, causing more than a hundred thousand deaths. This study aimed to describe the epidemic characteristics of SARS-CoV-2 and its transmission in a city in China.

Methods: This was a descriptive study on retrospective data collected from January to February 2020 from reports issued by the authority of Jining City, China, including data on travel history, transmission, gender, and age of infected persons.

Results: During the period January and February 2020, 52 cases were confirmed to be SARS-CoV-2 infections with more than half were males (n=32, 61.5%) and and in the age grup of 31–50 yars old (53.8%). The modes of transmission were mostly primary infections (n=23) and a history of travel to and from outside of Shandong Province (n=14). Interestingly, the infection was the 4th transmission and most primary infectious persons did not transmit the virus to others.

Conclusions: The key characters of infected people in Jining City in early epidemic time with the exception of exogenous inputs are male gender, city dweller, and middle-aged people of 31–50 years old. There is a restricted transmission in Jining City of China at the early phrase of the SARS-CoV-2 epidemic, indicating that the strategy for the fight against SARS-CoV-2 is effective to some extent and worth to be learned by the members of the global village. This strategy includes actions such as home isolation, collective centralized quarantine, social distancing, and face mask use.

Keywords

Jining City, panorama, SARS-CoV-2, transmission

Full Text:

PDF

References

WHO. WHO coronavirus disease (COVID-19) dashboard Data last updated: 2021/1/23, 4:57pm CET. 2021[cited 2021 January 23] Available from: https://covid19.who.int/.

Du W, Han S, Li Q, Zhang Z. Epidemic update of COVID-19 in Hubei Province compared with other regions in China. Int J Infect Dis. 2020;95:321–5.

Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020; 92(7):797–806.

Yang K, Xiao LY, Liu YF, Shi DY, Lu H , Li T, et al. Epidemiological and clinical characteristics of coronavirus disease 2019 in non-epidemic areas: report of 57 cases. J Third Mil Med Univ. 2020;42(6):555–9.

Yin X, Riva L, Pu Y, Martin-Sancho L, Kanamune J, Yamamoto Y, et al. MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep. 2021;34(2):108628.

Dong X. Confucious vs Einstein: who would be a better gerontologist? Innov Aging. 2018;2(Suppl 1):347.

Phan LT, Nguyen TV, Luong QC, Nguyen TV, Ngyyen HT, Le HQ, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020;382(9):872–4.

Zhou F, Yu T, Du R, Guan F, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.

Ryu S, Chun BC, Korean Society of Epidemiology 2019-nCoV Task Force Team. An interim review of the epidemiological characteristics of 2019 novel coronavirus. Epidemiol Health. 2020; 42:e2020006.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.

Fang XW, Mei Q, Yang TJ, Zhang L, Yang Y, Wang YZ, et al. Clinical characteristics and treatment strategies of 79 patients with COVID-19. Chinese Pharmacological Bulletin. 2020;36(4):12–8.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708–20.

Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706–11.

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiology characteristics of an outbreak of 2019 novel coronavirus disease (COVID-19) in China. Chin J Epidemiol. 2020;41(2):145–51.

Lin JF, Wu MN, Wu HC, Zhang T, Wu C, Li FD. Epidemiological characteristics of coronavirus diseases 2019 in Zhejiang Province. Preventive Medicine. 2020;32(3):217–221,225.

Jining Municiple Health Commission. The epidemic status of SARS-Cov-2 in Jining City. 2020 [cited 2020 January 18], Available from: http://wjw.jining.gov.cn/art/2020/2/18/art_59856_2452811.html

Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020; 395(10242):1973–87.

Liu W, Yue XG, Tchounwou PB. Response to the COVID-19 epidemic: the Chinese experience and implications for other countries. Int J Environ Res Public Health. 2020;17(7):2304.

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514–23.

DOI: https://doi.org/10.15850/amj.v8n2.2373